| Immunogenicity of a DNA vaccine candidate for COVID-19 TRF Smith, A Patel, S Ramos, D Elwood, X Zhu, J Yan, EN Gary, ... Nature communications 11 (1), 2601, 2020 | 703 | 2020 |
| Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial K Modjarrad, CC Roberts, KT Mills, AR Castellano, K Paolino, ... The Lancet Infectious Diseases 19 (9), 1013-1022, 2019 | 336 | 2019 |
| A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates K Muthumani, D Falzarano, EL Reuschel, C Tingey, S Flingai, ... Science translational medicine 7 (301), 301ra132-301ra132, 2015 | 275 | 2015 |
| Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial P Tebas, SP Yang, JD Boyer, EL Reuschel, A Patel, A Christensen-Quick, ... EClinicalMedicine 31, 2021 | 254 | 2021 |
| Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice MA Croyle, A Patel, KN Tran, M Gray, Y Zhang, JE Strong, H Feldmann, ... PloS one 3 (10), e3548, 2008 | 212 | 2008 |
| Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates G Wong, JS Richardson, S Pillet, A Patel, X Qiu, J Alimonti, J Hogan, ... Science translational medicine 4 (158), 158ra146-158ra146, 2012 | 184 | 2012 |
| Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs GP Kobinger, A Leung, J Neufeld, JS Richardson, D Falzarano, G Smith, ... Journal of Infectious Diseases 204 (2), 200-208, 2011 | 177 | 2011 |
| Intradermal SynCon® Ebola GP DNA vaccine is temperature stable and safely demonstrates cellular and humoral immunogenicity advantages in healthy volunteers P Tebas, KA Kraynyak, A Patel, JN Maslow, MP Morrow, AJ Sylvester, ... The Journal of infectious diseases 220 (3), 400-410, 2019 | 104 | 2019 |
| Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy S Flingai, EM Plummer, A Patel, S Shresta, JM Mendoza, KE Broderick, ... Scientific reports 5 (1), 12616, 2015 | 79 | 2015 |
| Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice A Patel, Y Zhang, M Croyle, K Tran, M Gray, J Strong, H Feldmann, ... The Journal of infectious diseases 196 (Supplement_2), S413-S420, 2007 | 71 | 2007 |
| Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus GP Kobinger, I Meunier, A Patel, S Pillet, J Gren, S Stebner, A Leung, ... The Journal of infectious diseases 201 (7), 1000-1006, 2010 | 69 | 2010 |
| Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device KE Broderick, X Shen, J Soderholm, F Lin, J McCoy, AS Khan, J Yan, ... Gene therapy 18 (3), 258-265, 2011 | 68 | 2011 |
| Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model A Patel, J Walters, EL Reuschel, K Schultheis, E Parzych, EN Gary, ... BioRxiv, 2020.07. 28.225649, 2020 | 67 | 2020 |
| An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model A Patel, A DiGiandomenico, AE Keller, TRF Smith, DH Park, S Ramos, ... Nature communications 8 (1), 637, 2017 | 62 | 2017 |
| Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination P Fagone, DJ Shedlock, H Bao, OU Kawalekar, J Yan, D Gupta, ... Gene therapy 18 (11), 1070-1077, 2011 | 62 | 2011 |
| SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients SN Walker, N Chokkalingam, EL Reuschel, M Purwar, Z Xu, EN Gary, ... Journal of Clinical Microbiology 58 (11), 10.1128/jcm. 01533-20, 2020 | 60 | 2020 |
| Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses A Patel, K Tran, M Gray, Y Li, Z Ao, X Yao, D Kobasa, GP Kobinger Vaccine 27 (23), 3083-3089, 2009 | 59 | 2009 |
| In vivo delivery of nucleic acid-encoded monoclonal antibodies A Patel, MA Bah, DB Weiner BioDrugs 34 (3), 273-293, 2020 | 54 | 2020 |
| DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections STC Elliott, NL Kallewaard, E Benjamin, L Wachter-Rosati, JM McAuliffe, ... npj Vaccines 2 (1), 18, 2017 | 51 | 2017 |
| Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo EK Duperret, A Trautz, R Stoltz, A Patel, MC Wise, A Perales-Puchalt, ... Cancer research 78 (22), 6363-6370, 2018 | 50 | 2018 |
